Cytokinetics, Inc. (CYTK)

[H2R]

CYTK Prices 5.36M Offering at $14.25/Sh

And where did the price go to today?

...$14.20 as of now. Close to a 10% drop! Too bad they could not get an around $15+/Sh. My guess is that in the upcoming months, the PPS will rise again past $15. Say by end of July.

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the pricing of an underwritten public offering of 5,260,000 shares of its common stock at a price to the public of $14.25 per share, before underwriting discounts and commissions. The gross proceeds to Cytokinetics from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Cytokinetics, are expected to be to be approximately $75.0 million. The offering is expected to close on May 12, 2017, subject to customary closing conditions. Additionally, Cytokinetics granted the underwriter a 30-day option to purchase up to an additional 789,000 shares of common stock at the public offering price, less underwriting discounts and commissions. All of the shares of common stock in the offering will be sold by Cytokinetics.

Morgan Stanley is acting as sole underwriter for the offering. A registration statement related to the offering has been filed with the Securities and Exchange Commission (the “SEC”). A preliminary prospectus supplement relating to and describing the terms of the offering was filed with the SEC and is available on the SEC’s website at www.sec.gov. Copies of the final prospectus supplement, when available, may be obtained from the offices of Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014.